Format

Send to

Choose Destination
Mol Psychiatry. 2019 Oct 21. doi: 10.1038/s41380-019-0529-7. [Epub ahead of print]

Correction: Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation.

Author information

1
Department of Medicine (General Internal Medicine), University of Washington, Seattle, WA, USA.
2
Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
3
John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL, USA.
4
Departments of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
5
Case Western Reserve University, Cleveland Heights, OH, USA.
6
Human Genome Sequencing Center and Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
7
Department of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA.
8
Department of Neuroscience and Ronald M Loeb Center for Alzheimer's Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
9
Department of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
10
University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
11
Erasmus University Medical Center, Rotterdam, Netherlands.
12
Inserm, U1167, RID-AGE-Risk Factors and Molecular Determinants of Aging-Related Diseases, Lille, France.
13
Institut Pasteur de Lille, Lille, France.
14
University Lille, U1167-Excellence Laboratory LabEx DISTALZ, Lille, France.
15
Department of Medical Genetics, Vanderbilt University Medical Center, Nashville, TN, USA.
16
Department of Genetics and CNR-MAJ, Normandie Université, UNIROUEN, Inserm U1245 and Rouen University Hospital, F 76000, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
17
Department of Research, Centre Hospitalier du Rouvray, Sotteville-lès-, Rouen, France.
18
Department of Psychiatry, Washington University, St. Louis, MO, USA.
19
National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA.
20
University of Bordeaux, Inserm, Bordeaux Population Health Research Center, team VINTAGE, UMR 1219, F-33000, Bordeaux, France.
21
Department of Neurology and Institute for Neurodegenerative Diseases, Bordeaux University Hospital, Memory Clinic, F-33000, Bordeaux, France.
22
Centre National de Recherche en Génomique Humaine, Institut François Jacob, Direction de le Recherche Fondamentale, CEA, Evry, France.
23
McDonnell Genome Institute, Washington University, St. Louis, MO, USA.
24
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
25
Inserm UMR-1078, CHRU Brest, Université Brest, Brest, France.
26
Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
27
National Institute for Health and Welfare, Helsinki, Finland.
28
Institute of Clinical Medicine - Neurology and Department of Neurology, University of Eastern Finland, Kuopio, Finland.
29
Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
30
Program in Medical and Population Genetics and Genetic Analysis Platform, Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
31
Psychiatric & Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
32
McGill University and Génome Québec Innovation Centre, Montréal, Canada.
33
Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
34
Department of Medicine (Computational Biomedicine), Boston University School of Medicine, Boston, MA, USA.
35
Columbia University, New York, NY, USA.
36
Indiana University School of Medicine, Indianapolis, IN, USA.
37
University of Tartu, Estonian Genome Center, Tartu, Estonia.
38
Department of Epidemiology, University of Washington, Seattle, WA, USA.
39
Department of Health Services, University of Washington, Seattle, WA, USA.
40
Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
41
Inserm, CNRS, Univ. Nantes, CHU Nantes, l'institut du thorax, Nantes, France.
42
Unit of Clinical Neuroscience, Neurology, University of Oulu and Medical Research Center, Oulu University Hospital, Oulu, Finland.
43
Department of Neurology, Clinical Division of Neurogeriatrics, Medical University of Graz, Graz, Austria.
44
Department of Neurology, Kuopio University Hospital, Kuopio, Finland.
45
Department of Statistics, University of Washington, Seattle, WA, USA.
46
Department of Medicine (Medical Genetics), University of Washington, Seattle, WA, USA.
47
Department of Biostatistics, University of Washington, Seattle, WA, USA.
48
School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA.
49
Departments of Neurology, Boston University School of Medicine, Boston, MA, USA.
50
Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, TX, USA.
51
Departments of Biostatistics, Boston University School of Public Health, Boston, MA, USA. farrer@bu.Edu.
52
Department of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA. farrer@bu.Edu.
53
Departments of Neurology, Boston University School of Medicine, Boston, MA, USA. farrer@bu.Edu.
54
Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA. farrer@bu.Edu.
55
Department of Ophthalmology, Boston University School of Medicine, Boston, MA, USA. farrer@bu.Edu.

Abstract

A correction to this paper has been published and can be accessed via a link at the top of the paper.

PMID:
31636380
DOI:
10.1038/s41380-019-0529-7

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center